Loading clinical trials...
Loading clinical trials...
Phase II Trial of Docetaxel With PI-88 in Patients With Advanced Non-Small-Cell Lung Cancer
Conditions
Interventions
docetaxel
PI-88
Locations
13
Australia
Sydney Cancer Centre, Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Sydney Haematology and Oncology Clinics
Hornsby, New South Wales, Australia
Prince of Wales Hospital
Randwick, New South Wales, Australia
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Newcastle Mater Misericordiae Hospital
Waratah, New South Wales, Australia
Prince Charles Hospital
Chermside, Queensland, Australia
Start Date
February 1, 2004
Completion Date
July 1, 2006
Last Updated
June 27, 2022
NCT06667908
NCT04165798
NCT06875310
NCT07046923
NCT07222566
NCT06667076
Lead Sponsor
Cellxpert Biotechnology Corp.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions